Expanded and Diverse Team

We are pleased to have added new members to our team and are proud of the diversity in the company. Our 50/50 gender balanced team of 14 people has representatives from 9 nationalities and ages from every decade from 20s to 60s. We apply this diversity of approach and background to innovation and problem-solving. In March… Read more »

Successful membrane safety study

A recent publication in British Journal of Ophthalmology by Professor Sheila MacNeil and colleagues at the University of Sheffield and the L.V. Prasad eye clinic in Hyderabad, described how electrospun membranes can be safely applied to rabbit corneas without inducing any local or systemic toxicity. The membranes, made from poly-lactic co-glycolic acid (PLGA) 50:50, were… Read more »

3D Cell Culture – London – 20-21 Feb 2019

SMi’s 3rd Annual Conference 3D Cell Culture February 20-21, 2019 | London, United Kingdom ————————————————————————- Cell Culture in an important tool for research and development within the life science industry. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers over conventional… Read more »

Appointment of chair

The Electrospinning Company has appointed Dr Stewart White as non-executive chairman. Previously CEO of two life science AIM-quoted companies including Collagen Solutions plc, Stewart is currently CEO of Novel Technologies Holdings Limited and Chairman of Mikota Ltd.  Stewart has international executive experience in commercialisation, product development, GMP manufacturing of medical devices, advanced biologics and API’s in both SMEs… Read more »

Innovation Loan for manufacturing scale-up

One of 17 businesses backed in the second round of innovation loans for innovative manufacturing processes and materials. The companies will use the funding to carry out R&D projects as part of plans to scale up production and commercialise new technologies. The Electrospinning Company has just moved into purpose-built clean-room facilities on the growing Harwell Science and Innovation… Read more »

We’ve moved!

Brand new, purpose-built facilities on the Harwell Science and Innovation Campus, a rapidly expanding innovation hub near Oxford in the UK. We are moving into our new unit (#5) in the Zephyr Building on 29th October. The 500 square metre unit is fitted out with four Class VII cleanroom modules, facilitating the segregation of R&D… Read more »

Multiple sclerosis repair roadmap

Research published in the journal Nature provides new understanding about how drugs can repair damaged brain cells that cause disability in patients with multiple sclerosis. Led by researchers at Case Western Reserve University School of Medicine, the study suggests new drug targets and potent early-stage drug candidates could lead to regenerative medicines for multiple sclerosis… Read more »